Cargando…
A Proteomic Study of Human Merkel Cell Carcinoma
Merkel Cell Carcinoma (MCC) is an aggressive neuroendocrine cancer of the skin. The incidence has been quadrupled with a 5-year mortality rate of 46%, presently there is no cure for metastatic disease. Despite the contribution of Merkel cell polyomavirus, the molecular events of MCC carcinogenesis a...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181674/ https://www.ncbi.nlm.nih.gov/pubmed/25284964 http://dx.doi.org/10.4172/jpb.1000291 |
_version_ | 1782337402496352256 |
---|---|
author | Shao, Qiang Byrum, Stephanie D. Moreland, Linley E. Mackintosh, Samuel G. Kannan, Aarthi Lin, Zhenyu Morgan, Michael Stack, Brendan C. Cornelius, Lynn A. Tackett, Alan J. Gao, Ling |
author_facet | Shao, Qiang Byrum, Stephanie D. Moreland, Linley E. Mackintosh, Samuel G. Kannan, Aarthi Lin, Zhenyu Morgan, Michael Stack, Brendan C. Cornelius, Lynn A. Tackett, Alan J. Gao, Ling |
author_sort | Shao, Qiang |
collection | PubMed |
description | Merkel Cell Carcinoma (MCC) is an aggressive neuroendocrine cancer of the skin. The incidence has been quadrupled with a 5-year mortality rate of 46%, presently there is no cure for metastatic disease. Despite the contribution of Merkel cell polyomavirus, the molecular events of MCC carcinogenesis are poorly defined. To better understand MCC carcinogensis, we have performed the first quantitative proteomic comparison of formalin-fixed, paraffin-embedded (FFPE) MCC tissues using another neuroendocrine tumor (carcinoid tumor of the lung) as controls. Bioinformatic analysis of the proteomic data has revealed that MCCs carry distinct protein expression patterns. Further analysis of significantly over-expressed proteins suggested the involvement of MAPK, PI3K/Akt/mTOR, wnt, and apoptosis signaling pathways. Our previous study and that from others have shown mTOR activation in MCCs. Therefore, we have focused on two downstream molecules of the mTOR pathway, lactate dehydrogenase B (LDHB) and heterogeneous ribonucleoprotein F (hnRNPF). We confirm over-expression of LDHB and hnRNPF in two primary human MCC cell lines, 16 fresh tumors, and in the majority of 80 tissue microarray samples. Moreover, mTOR inhibition suppresses LDHB and hnRNPF expression in MCC cells. The results of the current study provide insight into MCC carcinogenesis and provide rationale for mTOR inhibition in pre-clinical studies. |
format | Online Article Text |
id | pubmed-4181674 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
record_format | MEDLINE/PubMed |
spelling | pubmed-41816742014-10-02 A Proteomic Study of Human Merkel Cell Carcinoma Shao, Qiang Byrum, Stephanie D. Moreland, Linley E. Mackintosh, Samuel G. Kannan, Aarthi Lin, Zhenyu Morgan, Michael Stack, Brendan C. Cornelius, Lynn A. Tackett, Alan J. Gao, Ling J Proteomics Bioinform Article Merkel Cell Carcinoma (MCC) is an aggressive neuroendocrine cancer of the skin. The incidence has been quadrupled with a 5-year mortality rate of 46%, presently there is no cure for metastatic disease. Despite the contribution of Merkel cell polyomavirus, the molecular events of MCC carcinogenesis are poorly defined. To better understand MCC carcinogensis, we have performed the first quantitative proteomic comparison of formalin-fixed, paraffin-embedded (FFPE) MCC tissues using another neuroendocrine tumor (carcinoid tumor of the lung) as controls. Bioinformatic analysis of the proteomic data has revealed that MCCs carry distinct protein expression patterns. Further analysis of significantly over-expressed proteins suggested the involvement of MAPK, PI3K/Akt/mTOR, wnt, and apoptosis signaling pathways. Our previous study and that from others have shown mTOR activation in MCCs. Therefore, we have focused on two downstream molecules of the mTOR pathway, lactate dehydrogenase B (LDHB) and heterogeneous ribonucleoprotein F (hnRNPF). We confirm over-expression of LDHB and hnRNPF in two primary human MCC cell lines, 16 fresh tumors, and in the majority of 80 tissue microarray samples. Moreover, mTOR inhibition suppresses LDHB and hnRNPF expression in MCC cells. The results of the current study provide insight into MCC carcinogenesis and provide rationale for mTOR inhibition in pre-clinical studies. 2013-11-25 /pmc/articles/PMC4181674/ /pubmed/25284964 http://dx.doi.org/10.4172/jpb.1000291 Text en Copyright: © 2013 Shao Q, et al. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Article Shao, Qiang Byrum, Stephanie D. Moreland, Linley E. Mackintosh, Samuel G. Kannan, Aarthi Lin, Zhenyu Morgan, Michael Stack, Brendan C. Cornelius, Lynn A. Tackett, Alan J. Gao, Ling A Proteomic Study of Human Merkel Cell Carcinoma |
title | A Proteomic Study of Human Merkel Cell Carcinoma |
title_full | A Proteomic Study of Human Merkel Cell Carcinoma |
title_fullStr | A Proteomic Study of Human Merkel Cell Carcinoma |
title_full_unstemmed | A Proteomic Study of Human Merkel Cell Carcinoma |
title_short | A Proteomic Study of Human Merkel Cell Carcinoma |
title_sort | proteomic study of human merkel cell carcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181674/ https://www.ncbi.nlm.nih.gov/pubmed/25284964 http://dx.doi.org/10.4172/jpb.1000291 |
work_keys_str_mv | AT shaoqiang aproteomicstudyofhumanmerkelcellcarcinoma AT byrumstephanied aproteomicstudyofhumanmerkelcellcarcinoma AT morelandlinleye aproteomicstudyofhumanmerkelcellcarcinoma AT mackintoshsamuelg aproteomicstudyofhumanmerkelcellcarcinoma AT kannanaarthi aproteomicstudyofhumanmerkelcellcarcinoma AT linzhenyu aproteomicstudyofhumanmerkelcellcarcinoma AT morganmichael aproteomicstudyofhumanmerkelcellcarcinoma AT stackbrendanc aproteomicstudyofhumanmerkelcellcarcinoma AT corneliuslynna aproteomicstudyofhumanmerkelcellcarcinoma AT tackettalanj aproteomicstudyofhumanmerkelcellcarcinoma AT gaoling aproteomicstudyofhumanmerkelcellcarcinoma AT shaoqiang proteomicstudyofhumanmerkelcellcarcinoma AT byrumstephanied proteomicstudyofhumanmerkelcellcarcinoma AT morelandlinleye proteomicstudyofhumanmerkelcellcarcinoma AT mackintoshsamuelg proteomicstudyofhumanmerkelcellcarcinoma AT kannanaarthi proteomicstudyofhumanmerkelcellcarcinoma AT linzhenyu proteomicstudyofhumanmerkelcellcarcinoma AT morganmichael proteomicstudyofhumanmerkelcellcarcinoma AT stackbrendanc proteomicstudyofhumanmerkelcellcarcinoma AT corneliuslynna proteomicstudyofhumanmerkelcellcarcinoma AT tackettalanj proteomicstudyofhumanmerkelcellcarcinoma AT gaoling proteomicstudyofhumanmerkelcellcarcinoma |